Bacterial Infections Archives - Page 171 of 172 - MPR

Bacterial Infections

Supplemental NDA submitted for Prevnar 13 in older adults

Pfizer announced that it has submitted a supplemental NDA (sNDA) to the FDA to expand the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults ≥50 years of age for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

FDA approves 2-Minute IV injection of Cubicin

Cubist Pharmaceuticals announced that the FDA has approved a new administration method for Cubicin (daptomycin for injection) to include a once-a-day 2-minute intravenous (IV) injection.